Every version by contractor
Open a version for its full policy text, contracts, codes and related NCDs. Covered codes are the count of ICD-10-CM codes in the version's billing and coding article; a dash means the export attaches no coded article.
Which diagnoses each contractor covers
Across the 2 versions with a coded billing and coding article, 840 ICD-10-CM codes are covered by at least one contractor: 45 by every version and 795 (95%) by only some of them. L39297 (Wellpoint Federal) covers the most codes no other version lists (791). L38920 (CGS Administrators, LLC) leaves out the most codes that every other version covers (791), the version where a diagnosis accepted elsewhere is most often absent. The comparison is mechanical: it counts codes on the lists and does not weigh the policy text, frequency limits or documentation rules, which can matter as much as the list.
Unique codes appear on that version's covered list only; missing codes are covered by every other version but not by this one. Lists are the union of the coded billing and coding articles linked to each LCD (MCD release 2026-11-12).
Where the lists part
Three-character ICD-10-CM categories ranked by how many of their codes are covered by some versions and not others; a category near the top is where checking the local list matters most.
| Category | Category title (FY2027) | Codes that differ |
|---|---|---|
| M05 | Rheumatoid arthritis with rheumatoid factor | 208 |
| M06 | Other rheumatoid arthritis | 98 |
| C82 | Follicular lymphoma | 97 |
| C83 | Non-follicular lymphoma | 78 |
| C81 | Hodgkin lymphoma | 70 |
| C84 | Mature T/NK-cell lymphomas | 62 |
| C85 | Other specified and unspecified types of non-Hodgkin lymphoma | 40 |
| M33 | Dermatopolymyositis | 16 |
| T86 | Complications of transplanted organs and tissue | 11 |
| C91 | Lymphoid leukemia | 9 |
| M32 | Systemic lupus erythematosus (SLE) | 9 |
| L10 | Pemphigus | 8 |
Code-by-contractor sample
100 of the 795 codes covered by some versions and not others, codes that most versions cover first and no more than three per category in the first pass. Y means the version's covered list includes the code.
| ICD-10-CM | Description (FY2027) | L38920 | L39297 |
|---|---|---|---|
| B10.89 | Other human herpesvirus infection | — | Y |
| B20 | Human immunodeficiency virus [HIV] disease | — | Y |
| C79.32 | Secondary malignant neoplasm of cerebral meninges | — | Y |
| C79.40 | Secondary malignant neoplasm of unspecified part of nervous system | — | Y |
| C79.49 | Secondary malignant neoplasm of other parts of nervous system | — | Y |
| C81.00 | Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site | — | Y |
| C81.01 | Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of head, face, and neck | — | Y |
| C81.02 | Nodular lymphocyte predominant Hodgkin lymphoma, intrathoracic lymph nodes | — | Y |
| C82.00 | Follicular lymphoma grade I, unspecified site | — | Y |
| C82.01 | Follicular lymphoma grade I, lymph nodes of head, face, and neck | — | Y |
| C82.02 | Follicular lymphoma grade I, intrathoracic lymph nodes | — | Y |
| C83.00 | Small cell B-cell lymphoma, unspecified site | — | Y |
| C83.01 | Small cell B-cell lymphoma, lymph nodes of head, face, and neck | — | Y |
| C83.02 | Small cell B-cell lymphoma, intrathoracic lymph nodes | — | Y |
| C84.09 | Mycosis fungoides, extranodal and solid organ sites | — | Y |
| C84.0A | Mycosis fungoides, in remission | — | Y |
| C84.19 | Sezary disease, extranodal and solid organ sites | — | Y |
| C85.10 | Unspecified B-cell lymphoma, unspecified site | — | Y |
| C85.11 | Unspecified B-cell lymphoma, lymph nodes of head, face, and neck | — | Y |
| C85.12 | Unspecified B-cell lymphoma, intrathoracic lymph nodes | — | Y |
| C88.01 | Waldenstrom macroglobulinemia, in remission | — | Y |
| C88.40 | Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] not having achieved remission | — | Y |
| C88.41 | Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma], in remission | — | Y |
| C91.00 | Acute lymphoblastic leukemia not having achieved remission | — | Y |
| C91.01 | Acute lymphoblastic leukemia, in remission | — | Y |
| C91.02 | Acute lymphoblastic leukemia, in relapse | — | Y |
| C94.40 | Acute panmyelosis with myelofibrosis not having achieved remission | — | Y |
| C94.41 | Acute panmyelosis with myelofibrosis, in remission | — | Y |
| C94.42 | Acute panmyelosis with myelofibrosis, in relapse | — | Y |
| C96.4 | Sarcoma of dendritic cells (accessory cells) | — | Y |
| C96.9 | Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified | — | Y |
| C96.Z | Other specified malignant neoplasms of lymphoid, hematopoietic and related tissue | — | Y |
| D36.0 | Benign neoplasm of lymph nodes | — | Y |
| D47.1 | Chronic myeloproliferative disease | — | Y |
| D47.9 | Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified | — | Y |
| D47.Z1 | Post-transplant lymphoproliferative disorder (PTLD) | — | Y |
| D59.19 | Other autoimmune hemolytic anemia | — | Y |
| D59.8 | Other acquired hemolytic anemias | — | Y |
| D59.9 | Acquired hemolytic anemia, unspecified | — | Y |
| D68.32 | Hemorrhagic disorder due to extrinsic circulating anticoagulants | — | Y |
| D68.4 | Acquired coagulation factor deficiency | — | Y |
| D69.42 | Congenital and hereditary thrombocytopenia purpura | — | Y |
| D69.49 | Other primary thrombocytopenia | — | Y |
| D76.3 | Other histiocytosis syndromes | — | Y |
| D89.1 | Cryoglobulinemia | — | Y |
| D89.813 | Graft-versus-host disease, unspecified | — | Y |
| D89.84 | IgG4-related disease | — | Y |
| E05.00 | Thyrotoxicosis with diffuse goiter without thyrotoxic crisis or storm | — | Y |
| G04.82 | Acute flaccid myelitis | Y | — |
| G61.81 | Chronic inflammatory demyelinating polyneuritis | — | Y |
| G93.49 | Other encephalopathy | — | Y |
| I77.6 | Arteritis, unspecified | — | Y |
| I77.82 | Antineutrophilic cytoplasmic antibody [ANCA] vasculitis | — | Y |
| L10.0 | Pemphigus vulgaris | — | Y |
| L10.1 | Pemphigus vegetans | — | Y |
| L10.2 | Pemphigus foliaceous | — | Y |
| L12.1 | Cicatricial pemphigoid | — | Y |
| L12.2 | Chronic bullous disease of childhood | — | Y |
| L12.30 | Acquired epidermolysis bullosa, unspecified | — | Y |
| L13.0 | Dermatitis herpetiformis | — | Y |
| L13.1 | Subcorneal pustular dermatitis | — | Y |
| L13.8 | Other specified bullous disorders | — | Y |
| L14 | Bullous disorders in diseases classified elsewhere | — | Y |
| L40.1 | Generalized pustular psoriasis | — | Y |
| L51.2 | Toxic epidermal necrolysis [Lyell] | — | Y |
| M05.00 | Felty's syndrome, unspecified site | — | Y |
| M05.011 | Felty's syndrome, right shoulder | — | Y |
| M05.012 | Felty's syndrome, left shoulder | — | Y |
| M06.00 | Rheumatoid arthritis without rheumatoid factor, unspecified site | — | Y |
| M06.011 | Rheumatoid arthritis without rheumatoid factor, right shoulder | — | Y |
| M06.012 | Rheumatoid arthritis without rheumatoid factor, left shoulder | — | Y |
| M30.0 | Polyarteritis nodosa | — | Y |
| M30.1 | Polyarteritis with lung involvement [Churg-Strauss] | — | Y |
| M31.10 | Thrombotic microangiopathy, unspecified | — | Y |
| M31.30 | Wegener's granulomatosis without renal involvement | — | Y |
| M31.31 | Wegener's granulomatosis with renal involvement | — | Y |
| M32.0 | Drug-induced systemic lupus erythematosus | — | Y |
| M32.10 | Systemic lupus erythematosus, organ or system involvement unspecified | — | Y |
| M32.11 | Endocarditis in systemic lupus erythematosus | — | Y |
| M33.00 | Juvenile dermatomyositis, organ involvement unspecified | — | Y |
| M33.01 | Juvenile dermatomyositis with respiratory involvement | — | Y |
| M33.02 | Juvenile dermatomyositis with myopathy | — | Y |
| M34.0 | Progressive systemic sclerosis | — | Y |
| M34.1 | CR(E)ST syndrome | — | Y |
| M34.2 | Systemic sclerosis induced by drug and chemical | — | Y |
| M35.00 | Sjogren syndrome, unspecified | — | Y |
| M35.01 | Sjogren syndrome with keratoconjunctivitis | — | Y |
| M35.02 | Sjogren syndrome with lung involvement | — | Y |
| M36.0 | Dermato(poly)myositis in neoplastic disease | — | Y |
| N02.0 | Recurrent and persistent hematuria with minor glomerular abnormality | — | Y |
| N05.0 | Unspecified nephritic syndrome with minor glomerular abnormality | — | Y |
| N05.2 | Unspecified nephritic syndrome with diffuse membranous glomerulonephritis | Y | — |
| N18.6 | End stage renal disease | — | Y |
| R59.0 | Localized enlarged lymph nodes | — | Y |
| R59.1 | Generalized enlarged lymph nodes | — | Y |
| R59.9 | Enlarged lymph nodes, unspecified | — | Y |
| T86.00 | Unspecified complication of bone marrow transplant | — | Y |
| T86.09 | Other complications of bone marrow transplant | — | Y |
| T86.10 | Unspecified complication of kidney transplant | — | Y |
| Z51.6 | Encounter for desensitization to allergens | — | Y |
Download every covered code with a column per LCD (CSV). The LCD coverage variation report ranks every multi-contractor title by how far its lists diverge.
How to use the comparison
Start from the state where the service is furnished and open that contractor's version; its billing and coding article carries the diagnosis codes the claims system will test. For a group that bills in several jurisdictions, the version with the smallest covered list is the safe common denominator for pre-service review, and the version with the largest list shows what documentation can support an appeal elsewhere. The L39297 version is the one most searched for this title; the LCD lookup guide explains how jurisdictions are assigned, and the LCD hub lists every topic that more than one contractor has written.
For teams evaluating QuickIntell software
Where QuickIntell fits across jurisdictions
For teams working across MAC jurisdictions, evaluate how requirements, source policies and documentation review should be organized for each case. Confirm jurisdiction-specific scope and supported actions during a QuickAuth evaluation; compare claim and denial follow-up separately in QuickRCM.
Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.
Frequently asked questions
Why are there 2 LCDs called "Off-label Use of Rituximab and Rituximab Biosimilars"?
Each Medicare Administrative Contractor writes its own Local Coverage Determination for its jurisdiction. 2 contractors publish a policy with this title covering 12 states; they often start from one contractor's text and then revise separately, so dates, criteria and diagnosis lists differ by jurisdiction.
Which "Off-label Use of Rituximab and Rituximab Biosimilars" LCD applies to my claim?
The one written by the contractor that processes the claim: the A/B MAC for the state where the service is furnished, or the DME MAC region for equipment. The table lists each policy's states; open the policy for that jurisdiction and its billing and coding article.
How different are the diagnosis lists?
Across the 2 versions with a coded billing and coding article, 840 ICD-10-CM codes are covered by at least one contractor: 45 by every version and 795 (95%) by only some of them. A diagnosis accepted under one contractor's version can deny under another's, so a group that bills in several jurisdictions checks the list of the contractor that processes each claim.
When were these policies last revised?
Revision effective dates run from 2026-04-01 to 2026-07-30. A claim is judged against the version in force on the date of service.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- Medicare Coverage Database, current LCD exportVersion MCD release 2026-11-12 · effective 2026-11-08 · file lcd.csvSHA-256 2e0eda3351aa3d47…
- Medicare Coverage Database, current Billing and Coding Articles exportVersion MCD release 2026-11-12 · effective 2026-11-08 · file article.csvSHA-256 b475751458564786…
Disclaimer
Policy metadata and code counts are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing. Not legal, clinical or billing advice.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.